GLP1Wellness gLP1Wellness sells Retatrutide and Tirzepatide, positioning on 'the most competitive retatrutide price on the market' with a claimed '>99% purity third-party COA,' but names no laboratory and shows no company details. Patented-GLP-1 focus.
The Peptide Watch benchmarks every vendor on the same compound, BPC-157, the most common research peptide, as £ per milligram, so prices are directly comparable across all providers. No public BPC-157 price feed was available for this vendor at audit.
| Check | Result |
|---|---|
| Verifiable certificate in its own name | No |
| Independent lab named | None named / unverifiable |
| Tests its own stock | No evidence |